TechCrunch Disrupt 2026 is adding a dedicated Real World AI Stage, separating the practical challenges of deploying AI in physical environments from its existing AI programming.
The new stage, scheduled for October 13–15 at San Francisco’s Moscone West, will feature participants from Nvidia, Shield AI, Colossal Biosciences, FieldAI, Foxglove and other companies. Its agenda is a useful signal of where the next phase of AI commercialization is likely to be won or lost: not only in model capability, but in data collection, reliability, deployment constraints and industrial execution.
The bottleneck is not just the model
One session frames the central issue for robotics: physical systems lack the vast, readily available training corpora that helped large language models advance quickly. Self-driving programs have accumulated extensive driving data; general-purpose robots must contend with a far more varied set of environments, objects and tasks.
Nvidia’s head of physical AI, Les Karpas, is slated to discuss what would be required for a “ChatGPT moment” in robotics. For builders, the implication is straightforward: a compelling robot model is unlikely to be sufficient on its own. Companies will need repeatable pipelines for real-world data, simulation, evaluation and iteration.
That raises strategic questions for founders and operators. What proprietary data can a deployment generate? Which tasks can be reliably simulated? And does the business model support the ongoing collection, labeling and validation work required after an initial launch?
Safety becomes a product and company capability
The program also foregrounds a distinction often muted in software AI discussions: when a system controls or influences physical equipment, a bad output can cause immediate operational harm.
Shield AI CTO Nate Michael will lead a session on deploying AI in autonomous vehicles, defense technology and industrial systems. The stated focus includes safety culture, testing, validation, regulatory hurdles and earning user trust.
For executives evaluating physical AI, this is a reminder to treat assurance as more than a late-stage compliance exercise. Deployment readiness depends on defined operating boundaries, failure testing, monitoring and escalation paths. It also requires clarity about who is accountable when an AI system encounters conditions outside those boundaries.
In high-stakes sectors, the ability to demonstrate safe behavior may be as commercially important as model performance. Procurement cycles, insurance requirements and regulatory scrutiny can turn validation evidence into a competitive asset.
Edge constraints shape the architecture
Another session focuses on AI systems operating where cloud access is unreliable or unavailable, including defense, space and industrial contexts. FieldAI founder and CEO Ali Agha, Medra founder and CEO Michelle Lee, and Eclipse Ventures partner Aidan Madigan-Curtis are scheduled to discuss the architectural trade-offs.
For teams building in these environments, latency, bandwidth and resilience are core product requirements—not infrastructure details to defer. On-device or edge inference can reduce dependence on connectivity, but it creates constraints around compute, power, model size, updates and observability.
The practical question is not whether every workload can move to the edge. It is which decisions must happen locally, which data must be retained or transmitted, and how the system remains usable when a connection, sensor or upstream service fails.
Production is where deep tech economics are decided
The stage’s prototype-to-production panel will bring together leaders from MBRYONICS, Bedrock Robotics and Foxglove to address the gap between technical demonstrations, shipped products and profitable volume.
That gap is especially consequential for hardware-enabled AI businesses. A successful prototype does not establish supply-chain resilience, manufacturability, serviceability or unit economics. Founders should pressure-test those issues early, before customer commitments and custom deployments harden into an unscalable operating model.
The agenda also includes a session with Colossal Biosciences CEO Ben Lamm on AI’s role in modern biology and the debate around de-extinction. While distinct from robotics or edge systems, it reinforces the stage’s larger theme: AI is increasingly being applied to domains where biological, physical and social consequences extend beyond a screen.
What to watch next
The important development is not merely another conference track. It is the growing recognition that “real-world AI” requires a different scoreboard. Watch for companies that can show credible evidence across four areas: task-specific data advantages, measurable safety and reliability, workable edge architecture, and a realistic path to manufacturing or field-scale operations.
Those capabilities will determine which physical AI efforts graduate from impressive pilots to durable businesses.
